Subscribe to Newsletter

Content by Rob Coker:

Business & Regulation Business Practice

Driving the Future of Biopharma

| Rob Coker

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.

Business & Regulation Standards & Regulation

AstraZeneca Flu Vaccine Approved For Self-Administration

| Rob Coker

AstraZeneca’s FluMist is the first flu vaccine to be approved for self-administration.

Discovery & Development Drug Discovery

Cell Wars: A New Hope

| Rob Coker

Researchers use AI to reprogram glioblastoma cancer cells

Manufacture Advanced Medicine

Future Pharma

| Rob Coker | 4 min read

Ever wondered what the distant future of pharma and healthcare looks like? A group of industry experts offer their sage predictions.

Discovery & Development Translational Science

Of Mice and Monkeys

| Rob Coker | 3 min read

The contribution of macaques to advancing human understanding of flu-like viruses, including H5N1, cannot be overstated.

Discovery & Development Clinical Trials

Inhibitors Versus Diabetes … And Dementia!

| Rob Coker

Research suggests diabetes patients using SGLT-2 and DPP-4 inhibitors have a decreased risk of developing dementia.

Discovery & Development Drug Delivery

Mini Magnetic Medics

| Rob Coker

Nanorobots developed by engineers from the UK and China have delivered precision treatment to brain aneurysms

Discovery & Development Drug Delivery

Polio Vaccine Rollout in Gaza Commences

| Rob Coker | 2 min read

A campaign to vaccinate children against polio in Gaza has begun, but success will depend on the vital role of the pharmaceutical industry.

Business & Regulation COVID-19

Mpox Emergency

| Rob Coker | 2 min read

Vaccine manufacturers invited to take on mpox challenges

Discovery & Development Drug Discovery

Frederick Banting, We Salute You

| Rob Coker | 3 min read

Remembering the achievements in the short but successful life of insulin co-developer and Nobel Prize laureate Frederick Banting.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register